Lista de obras -

155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication

artículo científico publicado en 2017

A 72-bp internal deletion in the left inverted terminal repeat of the bovine adenovirus type 3 genome does not affect virus replication

artículo científico publicado en 2002

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose

A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

artículo científico publicado en 2008

A highly immunogenic vaccine against A/H7N9 influenza virus

artículo científico publicado en 2016

A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations

artículo científico publicado en 2020

Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein

artículo científico publicado en 2013

Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal

artículo científico publicado en 2017

Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging.

artículo científico publicado en 2015

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

scientific article published on 01 October 2020

Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice

scientific article published on 23 July 2013

Adenoviral vector immunity: its implications and circumvention strategies

artículo científico publicado en 2011

Adenoviral vector-based strategies for cancer therapy

scientific article published on May 2009

Adenovirus receptors and their implications in gene delivery

artículo científico publicado en 2009

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

artículo científico publicado en 2017

Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target

artículo científico publicado en 2010

Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time

artículo científico publicado en 2013

Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus

artículo científico publicado en 2008

Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry

scientific article published on 30 July 2009

Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3.

artículo científico publicado en 2005

Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness

artículo científico publicado en 2013

Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines

artículo científico publicado en 2002

Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

artículo científico publicado en 2009

Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture

artículo científico publicado en 2005

Components of Adenovirus Genome Packaging

artículo científico publicado en 2016

Corrigendum: KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors

artículo científico publicado en 2017

Current Use of Adenovirus Vectors and Their Production Methods

article

Current strategies and future directions for eluding adenoviral vector immunity

artículo científico publicado en 2006

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

artículo científico publicado en 2004

Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted

artículo científico publicado en 2002

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

artículo científico publicado en 2006

Development of nonhuman adenoviruses as vaccine vectors

artículo científico publicado en 2005

Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer

artículo científico publicado en 2020

Efficiency of Airborne Sample Analysis Platform (ASAP) bioaerosol sampler for pathogen detection

artículo científico publicado en 2015

Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.

artículo científico publicado en 2010

EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model

artículo científico publicado en 2012

Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model

artículo científico publicado en 2010

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder

artículo científico publicado en 2006

Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors.

artículo científico publicado en 2018

Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy

artículo científico publicado en 2005

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine

artículo científico publicado en 2012

KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors

artículo científico publicado en 2017

Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy

scholarly article by Ekramy E Sayedahmed et al published 29 October 2018 in Vaccine

Modulation of PKR activity in cells infected by bovine viral diarrhea virus

artículo científico publicado en 2005

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses.

artículo científico publicado en 2018

Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines ⬇️

artículo científico publicado el 16 de agosto de 2011

Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture

artículo científico publicado en 2004

Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin

artículo científico publicado en 2005

Porcine circovirus type 2 (PCV2) causes apoptosis in experimentally inoculated BALB/c mice.

artículo científico publicado en 2005

Potassium Channel-Associated Bioelectricity of the Dermomyotome Determines Fin Patterning in Zebrafish

artículo científico publicado en 2020

Production of adenovirus vectors and their use as a delivery system for influenza vaccines ⬇️

artículo científico publicado el 1 de octubre de 2010

Respiratory Viruses of Animals Causing Disease in Humans--Keystone Symposium

artículo científico publicado en 2007

Sequence analysis of old and new strains of porcine circovirus associated with congenital tremors in pigs and their comparison with strains involved with postweaning multisystemic wasting syndrome

artículo científico publicado en 2002

Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer ⬇️

artículo científico publicado el 29 de septiembre de 2011

Vaccine approaches conferring cross-protection against influenza viruses

artículo científico publicado en 2017

Lista de obras de

155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication

A 72-bp internal deletion in the left inverted terminal repeat of the bovine adenovirus type 3 genome does not affect virus replication

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose

A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

A highly immunogenic vaccine against A/H7N9 influenza virus

A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations

Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein

Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal

Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging.

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice

Adenoviral vector immunity: its implications and circumvention strategies

Adenoviral vector-based strategies for cancer therapy

Adenovirus receptors and their implications in gene delivery

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target

Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time

Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus

Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry

Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3.

Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness

Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines

Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture

Components of Adenovirus Genome Packaging

Corrigendum: KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors

Current Use of Adenovirus Vectors and Their Production Methods

Current strategies and future directions for eluding adenoviral vector immunity

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

Development of nonhuman adenoviruses as vaccine vectors

Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer

Efficiency of Airborne Sample Analysis Platform (ASAP) bioaerosol sampler for pathogen detection

Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.

EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model

Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder

Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors.

Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine

KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors

Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy

Modulation of PKR activity in cells infected by bovine viral diarrhea virus

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses.

Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines ⬇️

Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture

Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin

Porcine circovirus type 2 (PCV2) causes apoptosis in experimentally inoculated BALB/c mice.

Potassium Channel-Associated Bioelectricity of the Dermomyotome Determines Fin Patterning in Zebrafish

Production of adenovirus vectors and their use as a delivery system for influenza vaccines ⬇️

Respiratory Viruses of Animals Causing Disease in Humans--Keystone Symposium

Sequence analysis of old and new strains of porcine circovirus associated with congenital tremors in pigs and their comparison with strains involved with postweaning multisystemic wasting syndrome

Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer ⬇️

Vaccine approaches conferring cross-protection against influenza viruses